Abstract
Cardiac amyloidosis (CA) is an underdiagnosed disease with several effective treatments. The diagnosis of cardiac amyloidosis can be obtained rapidly with the availability of multiple imaging modalities each with relative benefits and contraindications. While current imaging modalities are safe and accurate for the purposes of diagnosing CA, their roles continue to evolve
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-Evidence base and standardized methods of imaging. J Nucl Cardiol. 2019;26(6):2065–123. https://doi.org/10.1007/s12350-019-01760-6.
Dorbala S, Ando Y, Bokhari S, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2-Diagnostic criteria and appropriate utilization. J Nucl Cardiol. 2020;27(2):659–73. https://doi.org/10.1007/s12350-019-01761-5.
Kittleson MM, Maurer MS, Ambardekar AV, et al. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020;142(1):e7–e22. https://doi.org/10.1161/CIR.0000000000000792.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Horblitt, A. (2022). Amyloid Imaging. In: Hendel, R.C., Kimmelstiel, C. (eds) Cardiology Procedures. Springer, Cham. https://doi.org/10.1007/978-3-030-95259-4_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-95259-4_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-95258-7
Online ISBN: 978-3-030-95259-4
eBook Packages: MedicineMedicine (R0)